The first regional event of Institute for Value-Based Medicine,® {IVBM), held in Boston, Massachusetts, in September 2024, brought together top minds from the top cancer centers in Massachusetts and Connecticut to examine the fine line between wanting to take value-based cancer care to the next level and considering how to bring advancements in precision medicine and targeted treatment to patients who not only need them but meet criteria to receive them.
It was the first time an IVBM event was held in Boston, and the theme was “Elevating Value in Cancer Care.” The faculty examined top-of-mind issues in oncology: immunotherapy advancements in non–small cell lung cancer (NSCLC), targeting HER2 in breast cancer, identifying predictive biomarkers for sarcomas, and pharmacy decision-making in value-based oncology care.